Regen is an Iranian Tissue Product Company that specializes in the production and distribution of allograft products. Established in 2012 with the support of Tehran University of Medical Sciences, Regen has become a pioneer in allograft processing in Iran. The company adheres to international standards and holds the necessary licenses for production and exploitation from the Iranian Food and Drug Administration and Ministry of Industry, Mine, and Trade.

Regen's allograft products are widely used as scaffolds, volumizing agents, and biologic dressings in various medical fields, including orthopedic and spine surgery, dentistry, dermatology, and more. They are considered the gold standard in tissue lesion reconstructions. Notably, Regen's products are cost-effective as the tissues used are obtained from donors.

The company ensures quality, effectiveness, and safety by following the guidelines set by the American Association of Tissue Banks, conducting thorough serological and microbial tests, and performing sterilization with gamma rays. With continuous regulations and stringent quality control measures, Regen strives to improve the quality of life through tissue transplantation